Azenta (AZTA) Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AZTA shares.
View AZTA analyst ratings or view top-rated stocks.

4 analysts have issued twelve-month price targets for Azenta's stock. Their AZTA share price forecasts range from $55.00 to $70.00. On average, they expect the company's stock price to reach $64.20 in the next year. This suggests a possible upside of 43.6% from the stock's current price.
View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts.

Azenta's stock was trading at $58.22 at the beginning of the year. Since then, AZTA stock has decreased by 23.2% and is now trading at $44.72.
View the best growth stocks for 2023 here.

Azenta saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 5,980,000 shares, a decrease of 15.4% from the April 30th total of 7,070,000 shares. Based on an average daily volume of 1,200,000 shares, the short-interest ratio is currently 5.0 days. Approximately 9.4% of the company's shares are short sold.
View Azenta's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AZTA earnings forecast.

Azenta, Inc. (NASDAQ:AZTA) posted its earnings results on Tuesday, May, 9th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The business had revenue of $148.40 million for the quarter, compared to analysts' expectations of $161.90 million. Azenta had a positive trailing twelve-month return on equity of 0.81% and a negative net margin of 7.79%. Azenta's revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.12 EPS.

ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Robotics & Automation ETF (ROBO), Harbor Health Care ETF (MEDI), ROBO Global Healthcare Technology and Innovation ETF (HTEC), BlackRock Future Innovators ETF (BFTR), Syntax Stratified MidCap ETF (SMDY), Invesco S&P MidCap Quality ETF (XMHQ), Invesco Nasdaq Future Gen 200 ETF (QQQS) and Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC).

Azenta updated its third quarter earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of ($0.07)-$0.03 for the period, compared to the consensus EPS estimate of $0.06. The company issued revenue guidance of $150-$168 million, compared to the consensus revenue estimate of $170.72 million.

Azenta trades on the NASDAQ under the ticker symbol "AZTA."

Azenta's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (9.81%), Kayne Anderson Rudnick Investment Management LLC (6.46%), JPMorgan Chase & Co. (4.63%), Allspring Global Investments Holdings LLC (3.43%), State Street Corp (3.03%) and Brown Advisory Inc. (2.60%). Insiders that own company stock include Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends.

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AZTA stock can currently be purchased for approximately $44.72.

Azenta (NASDAQ:AZTA) has a market capitalization of $2.91 billion and generates $555.50 million in revenue each year. The company earns $2.13 billion in net income (profit) each year or ($0.63) on an earnings per share basis.

The company employs 3,600 workers across the globe.

Azenta's mailing address is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. The official website for the company is www.brooks.com. The company can be reached via phone at (978) 262-2400, via email at investor@brooks.com, or via fax at 978-262-2500.